201 related articles for article (PubMed ID: 22160018)
1. Clonal evolution in aplastic anemia.
Afable MG; Tiu RV; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2011; 2011():90-5. PubMed ID: 22160018
[TBL] [Abstract][Full Text] [Related]
2. [Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes].
Passweg JR
Ther Umsch; 2010 May; 67(5):251-5. PubMed ID: 20509122
[TBL] [Abstract][Full Text] [Related]
3. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
Durrani J; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):97-104. PubMed ID: 31808900
[TBL] [Abstract][Full Text] [Related]
5. [Clonal chromosomal aberrations in patients with aplastic anemia at the disease onset and transformation].
Ol'shanskaia IuV; Mikhaĭlova EA; Domracheva EV; Udovichenko AI; Davidian IuR; Vodinskaia LA; Zakharova AV; Kokhno AV; Kaplanskaia IB; Tikhonova LIu; Tsvetaeva NV; Parovichnikova EN; Savchenko VG
Ter Arkh; 2006; 78(7):31-4, 36-7. PubMed ID: 16944748
[TBL] [Abstract][Full Text] [Related]
6. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
Maciejewski JP; Risitano A; Sloand EM; Nunez O; Young NS
Blood; 2002 May; 99(9):3129-35. PubMed ID: 11964274
[TBL] [Abstract][Full Text] [Related]
7. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria.
Gurnari C; Pagliuca S; Prata PH; Galimard JE; Catto LFB; Larcher L; Sebert M; Allain V; Patel BJ; Durmaz A; Pinto AL; Inacio MCB; Hernandez L; Dhedin N; Caillat-Zucman S; Clappier E; Sicre de Fontbrune F; Voso MT; Visconte V; Peffault de Latour R; Soulier J; Calado RT; Socié G; Maciejewski JP
J Clin Oncol; 2023 Jan; 41(1):132-142. PubMed ID: 36054881
[TBL] [Abstract][Full Text] [Related]
9. Early Detection of Myelodysplastic Syndrome/Leukemia-associated Mutations Using NGS Is Critical in Treating Aplastic Anemia.
Li X; Wu YH; Cai SS; Li WM; You Y; Zhang M
Curr Med Sci; 2019 Apr; 39(2):217-221. PubMed ID: 31016513
[TBL] [Abstract][Full Text] [Related]
10. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.
Afable MG; Wlodarski M; Makishima H; Shaik M; Sekeres MA; Tiu RV; Kalaycio M; O'Keefe CL; Maciejewski JP
Blood; 2011 Jun; 117(25):6876-84. PubMed ID: 21527527
[TBL] [Abstract][Full Text] [Related]
11. [Study on clonal evolution of monosomy 7 in patients with aplastic anemia by interphase- fluorescence in situ hybridization].
Li YM; Liu XP; Li CW; Xu FY; Gong JY; Yu CL; Wang JX; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2010 Oct; 31(10):688-92. PubMed ID: 21223721
[TBL] [Abstract][Full Text] [Related]
12. Somatic Mutations in Aplastic Anemia.
Mufti GJ; Marsh JCW
Hematol Oncol Clin North Am; 2018 Aug; 32(4):595-607. PubMed ID: 30047413
[TBL] [Abstract][Full Text] [Related]
13. [Cytogenetic studies on 334 myelodysplastic syndrome (MDS), aplastic anemia (AA) and other hematological diseases].
Feng BZ; Lei JL; Han JZ
Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):754-7. PubMed ID: 7600865
[TBL] [Abstract][Full Text] [Related]
14. Late clonal diseases of treated aplastic anemia.
Socié G; Rosenfeld S; Frickhofen N; Gluckman E; Tichelli A
Semin Hematol; 2000 Jan; 37(1):91-101. PubMed ID: 10676914
[TBL] [Abstract][Full Text] [Related]
15. The evidence of clonal evolution with monosomy 7 in aplastic anemia following granulocyte colony-stimulating factor using the polymerase chain reaction.
Yamazaki E; Kanamori H; Taguchi J; Harano H; Mohri H; Okubo T
Blood Cells Mol Dis; 1997 Aug; 23(2):213-8. PubMed ID: 9236159
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children.
Kojima S; Ohara A; Tsuchida M; Kudoh T; Hanada R; Okimoto Y; Kaneko T; Takano T; Ikuta K; Tsukimoto I;
Blood; 2002 Aug; 100(3):786-90. PubMed ID: 12130487
[TBL] [Abstract][Full Text] [Related]
17. Origins of myelodysplastic syndromes after aplastic anemia.
Negoro E; Nagata Y; Clemente MJ; Hosono N; Shen W; Nazha A; Yoshizato T; Hirsch C; Przychodzen B; Mahfouz RZ; Kuzmanovic T; Sekeres MA; Makishima H; Ogawa S; Maciejewski JP
Blood; 2017 Oct; 130(17):1953-1957. PubMed ID: 28893734
[No Abstract] [Full Text] [Related]
18. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
Barrett J; Saunthararajah Y; Molldrem J
Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
[TBL] [Abstract][Full Text] [Related]
19. Evolution of clonal cytogenetic abnormalities in aplastic anemia.
Maciejewski JP; Selleri C
Leuk Lymphoma; 2004 Mar; 45(3):433-40. PubMed ID: 15160903
[TBL] [Abstract][Full Text] [Related]
20. Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia.
Betensky M; Babushok D; Roth JJ; Mason PJ; Biegel JA; Busse TM; Li Y; Lind C; Papazoglou A; Monos D; Podsakoff G; Bessler M; Olson TS
Cancer Genet; 2016; 209(1-2):1-10. PubMed ID: 26702937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
